Zeo ScientifiX, Inc.

ZEOX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Apr 2026 Jan 2026 Oct 2025 Jul 2025 Apr 2025 Jan 2025 Oct 2024 Jul 2024
Assets
Cash & Equivalents $1.8M $1.0M $221.0K $314.0K $542.0K $720.0K $657.0K $1.1M
Accounts Receivable $276.0K $63.0K $35.0K — $11.0K $6.0K $194.0K $19.0K
Inventory $686.0K $502.0K $423.0K $258.0K $235.0K $245.0K $232.0K $250.0K
Total Current Assets $3.3M $2.0M $958.0K $1.1M $865.0K $1.1M $1.2M $1.7M
Property, Plant & Equipment $609.0K $564.0K $569.0K $589.0K $570.0K $460.0K $478.0K $496.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $3.9M $2.6M $1.5M $1.7M $1.4M $1.6M $1.6M $2.2M
Liabilities
Accounts Payable — — — — — — — —
Total Current Liabilities $3.1M $2.9M $2.9M $3.9M $3.5M $3.3M $3.3M $3.6M
Long-Term Debt — — — — — — — $51.0K
Total Liabilities $3.2M $3.0M $3.0M $4.0M $3.5M $3.4M $3.3M $3.6M
Stockholders' Equity
Retained Earnings $-68.7M $-68.6M $-67.7M $-66.9M $-64.8M $-63.5M $-62.2M $-61.0M
Total Stockholders' Equity $712.0K $-383.0K $-1.4M $-2.3M $-2.1M $-1.8M $-1.7M $-1.4M
← Newer Page 1 of 7 Older →